Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2)

ClinicalTrials.gov ID: NCT05327296

Public ClinicalTrials.gov record NCT05327296. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 4:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Controlled, Open Label, Assessor-Blinded Study to Evaluate the Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study to compare safety and efficacy of inhaled isoflurane administered via the Sedaconda ACD-S device system versus intravenous propofol for sedation of mechanically ventilated patients in the Intensive Care Unit (ICU) setting.

Study identification

NCT ID
NCT05327296
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sedana Medical
Industry
Enrollment
282 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2022 (Actual)
Primary completion
May 28, 2024 (Actual)
Completion
Nov 14, 2024 (Actual)
Last update posted
Mar 24, 2026

2022 – 2024

United States locations

U.S. sites
16
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
Memorial Health Services Long Beach California 90807 —
University of California, Los Angeles Los Angeles California 90095 —
Stanford University Redwood City California 94063 —
University of California, San Diego San Diego California 92023 —
University of Miami Coral Gables Florida 33146 —
Rush University Medical Center Chicago Illinois 60612 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
University of Michigan Ann Arbor Michigan 48109 —
Henry Ford Health System Detroit Michigan 48202 —
The Cooper Health System Camden New Jersey 08103 —
The New York and Presbyterian Hospital New York New York 10032 —
Ohio State University Columbus Ohio 43210 —
Thomas Jefferson University Philadelphia Pennsylvania 19107 —
Memorial Hermann Health Services Houston Texas 77030 —
Virginia Commonwealth University Richmond Virginia 23284 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05327296, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 24, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05327296 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →